Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-09-28 4:38 pm Sale | 2023-09-26 | 13D | Reata Pharmaceuticals, Inc. RETA | BIOGEN INC. BIIB | 0 0.000% | -8,936,791 (Position Closed) | Filing History |
| 2023-09-28 4:30 pm Sale | 2023-09-26 | 13D | Reata Pharmaceuticals, Inc. RETA | CPMG Inc | 0 0.000% | -5,020,431 (Position Closed) | Filing History |
| 2023-09-26 4:32 pm Sale | 2023-09-26 | 13D | Reata Pharmaceuticals, Inc. RETA | ROSE WILLIAM | 0 0.000% | -3,182,950 (Position Closed) | Filing History |
| 2023-09-19 4:31 pm Sale | 2023-09-15 | 13D | Reata Pharmaceuticals, Inc. RETA | ROSE WILLIAM | 3,182,950 8.900% | -58,000 (-1.79%) | Filing History |
| 2023-08-24 4:40 pm Unchanged | 2023-08-23 | 13D | Reata Pharmaceuticals, Inc. RETA | ROSE WILLIAM | 3,240,950 9.100% | 0 (Unchanged) | Filing History |
| 2023-08-07 5:21 pm Purchase | 2023-07-28 | 13D | Reata Pharmaceuticals, Inc. RETA | BIOGEN INC. BIIB | 8,936,791 23.400% | 8,936,791 (New Position) | Filing History |
| 2023-08-01 5:17 pm Sale | 2023-07-28 | 13D | Reata Pharmaceuticals, Inc. RETA | CPMG Inc | 5,020,431 14.300% | -9,625 (-0.19%) | Filing History |
| 2023-07-31 4:56 pm Purchase | 2023-07-28 | 13D | Reata Pharmaceuticals, Inc. RETA | ROSE WILLIAM | 3,240,950 9.200% | 25,250 (+0.79%) | Filing History |
| 2023-06-26 4:46 pm Purchase | 2023-06-16 | 13G | Reata Pharmaceuticals, Inc. RETA | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,730,841 5.240% | 1,730,841 (New Position) | Filing History |
| 2023-05-15 4:22 pm Sale | 2023-05-12 | 13G | Reata Pharmaceuticals, Inc. RETA | First Light Asset Management, LLC | 1,319,487 4.000% | -865,359 (-39.61%) | Filing History |
| 2023-03-07 11:25 am Purchase | 2023-03-06 | 13G | Reata Pharmaceuticals, Inc. RETA | Perceptive Advisors LLC | 2,083,799 6.500% | 2,083,799 (New Position) | Filing History |
| 2023-02-14 4:34 pm Purchase | 2022-12-31 | 13G | Reata Pharmaceuticals, Inc. RETA | First Light Asset Management, LLC | 2,184,846 6.890% | 2,184,846 (New Position) | Filing History |
| 2023-02-14 4:12 pm Sale | 2022-12-31 | 13G | Reata Pharmaceuticals, Inc. RETA | Point72 Asset Management, L.P. | 10,673 0.100% | -1,653,394 (-99.36%) | Filing History |
| 2023-02-09 5:47 pm Sale | 2022-12-31 | 13G | Reata Pharmaceuticals, Inc. RETA | EcoR1 Capital, LLC | 0 0.000% | -1,975,611 (Position Closed) | Filing History |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | Reata Pharmaceuticals, Inc. RETA | VANGUARD GROUP INC | 2,705,656 8.530% | 147,983 (+5.79%) | Filing History |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Reata Pharmaceuticals, Inc. RETA | BlackRock Inc. BLK | 2,501,693 7.900% | 387,643 (+18.34%) | Filing History |
| 2022-09-22 4:40 pm Purchase | 2022-09-21 | 13G | Reata Pharmaceuticals, Inc. RETA | Point72 Asset Management, L.P. | 1,664,067 5.300% | 1,664,067 (New Position) | Filing History |
| 2022-09-09 10:26 am Sale | 2022-08-31 | 13G | Reata Pharmaceuticals, Inc. RETA | WELLINGTON MANAGEMENT GROUP LLP | 1,508,638 4.780% | -2,744,339 (-64.53%) | Filing History |
| 2022-04-11 4:26 pm Purchase | 2022-03-31 | 13G | Reata Pharmaceuticals, Inc. RETA | EcoR1 Capital, LLC | 1,975,611 6.300% | 1,975,611 (New Position) | Filing History |
| 2022-03-10 11:32 am Sale | 2022-03-10 | 13G | Reata Pharmaceuticals, Inc. RETA | Invesco Ltd. IVZ | 372,165 1.200% | -1,908,244 (-83.68%) | Filing History |